Boston Trust Walden’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.6M Sell
50,451
-15,973
-24% -$4.99M 0.13% 181
2026
Q2
$28.8M Buy
66,424
+1,474
+2% +$447K 0.22% 156
2026
Q1
$13.9M Buy
64,950
+62,990
+3,214% +$14.1M 0.11% 197
2025
Q4
$336K Hold
1,960
– – ﹤0.01% 353
2025
Q3
$262K Buy
+1,960
New +$208K ﹤0.01% 371
2024
Q3
– Sell
-1,960
Closed -$209K – 392
2024
Q2
$209K Buy
+1,960
New +$188K ﹤0.01% 373

Other funds holding LRCX

Boston Trust Walden's LRCX Position: Q3 2026 in Review

Boston Trust Walden reduced its Lam Research (LRCX) stake by 24% in Q3 2026, selling an estimated $4.99M and leaving 50,451 shares worth $16.6M. The position accounts for 0.13% of the portfolio, ranked #181.

Boston Trust Walden first reported a position in LRCX in Q2 2024 and has held it in 6 quarters since. The position peaked at $28.8M in Q2 2026. 2,967 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

  • Boston Trust Walden held 50,451 shares of Lam Research worth $16.6M as of Q3 2026.
  • Boston Trust Walden sold 15,973 Lam Research shares in Q3 2026, an estimated $4.99M.
  • Lam Research made up 0.13% of Boston Trust Walden's portfolio in Q3 2026, its #181 holding.
  • Boston Trust Walden first reported a position in Lam Research in Q2 2024 and has held it in 6 quarters since.
  • Boston Trust Walden's Lam Research position peaked at $28.8M in Q2 2026.
  • 2,967 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Boston Trust Walden's 13F filing for Q3 2026, filed 30 Oct 2026.